Modified Valsalva and much more: lessons learned from the REVERT trial

Eur J Emerg Med. 2016 Dec;23(6):458-459. doi: 10.1097/MEJ.0000000000000373.

Authors

Youri Yordanov¹, Anthony Chauvin, Dominique Pateron

Affiliation

¹ aEmergency Department, Hôpital Saint-Antoine bEmergency Department, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris cEpidemiology and statistics research centre, INSERM U1153 dFaculté de Médecine, Université Pierre et Marie Curie, Paris, France.

PMID: 27755148
DOI: 10.1097/MEJ.0000000000000373

No abstract available

Publication types

Comment